Oocyte selection in contemporary clinical IVF: Do follicular markers of oocyte competence exist?

Human Preimplantation Embryo Selection

Volumn , Issue , 2007, Pages 301-323

  Van Blerkom, Jonathan ^a   Trout, Susan W ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b ROSE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85128442410     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (126)

1. Edwards R. Causes of early embryonic loss in human pregnancy. Hum Reprod 1986; 1: 185-98.
2. Van Blerkom J. Developmental failure in human reproduction associated with chromosomal abnormalities and cytoplasmic pathologies in meiotically mature oocyes. In. Van Blerkom J, ed. The Biological Basis of Early Human Reproductive Failure. Oxford: Oxford University Press, 1994: 283-326.
3. Plachot M. Genetic analysis of the oocyte - a review. Placenta 2003; 24 (Suppl 2): S66-72.
4. Makabe S, Van Blerkom J. An Atlas of Human Female Reproductive Function: Ovarian Development to Early Embryogenesis after in vitro Fertilization. New York: Taylor and Francis, 2006.
5. Motta PM, Nottola SA, Familiari G et al. Morphodynamics of the follicular-luteal complex during early ovarian development and reproductive life. Int Rev Cytol 2003; 223: 177-288.
6. Sandalinas M, Sadowy S, Alikani M et al. Developmental ability. of chromosomally abnormal human embryos to develop to the blastocyst stage. Hum Reprod 2001; 16: 1954-8.
7. Verlinsky Y, Kuliev A. An Atlas of Preimplantation Genetic Diagnosis. New York; Parthenon Publishing, 2000.
8. Van Blerkom J, Henry G. Oocyte dysmorphism and aneuploidy in meiotically mature human oocytes after controlled ovarian stimulation. Hum Reprod 1992; 7: 379-90.
9. Meriano J, Alexis J, Visram-Zaver S et al. Tracking of oocyte dysmorphisms for ICSI patients may prove relevant to the outcome in subsequent patient cycles. Hum Reprod 2001; 16: 2118-23.
10. Mikkelsen A, Lindenberg S. Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality. Hum Reprod 2001; 16: 1714-18.
11. Otsuki J, Okada K, Morimoto Y et al. The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod 2004; 19: 1591-7.
12. Ciotti P, Notarangelo A, Morselli-Labate V et al. First polar body morphology before ICSI is not related to embryo quality or pregnancy rate. Hum Reprod 2004; 19: 2334-9.
13. Eichenlaub-Ritter U, Sun F. Maternal age and oocyte competence. In Van Blerkom J, Gregory L, eds. Essential IVF: Basic Research and Clinical Applications. Boston: Kluwer Academic Publishers, 2004: 201-30.
14. Akande V, Flemming C, Hunt L, Keay S, Jenkins J. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod 2002; 17: 2002-8.
15. Simonetti S, Veeck L, Jones H, Jr. Correlation of follicular fluid volume with oocyte morphology from follicles stimulated by human menopausal gonadotropin. Fertil Steril 1985; 44: 177-80.
16. Wittmaack F, Kreger D, Blasco L et al. Effect of follicular size on oocyte retrieval, fertilization, cleavage, embryo quality in in vitro fertilization cycles: a 6-year data collection. Fertil Steril 1994; 62: 1205-10.
17. Dubey A, Wang H, Duffy P, Penzias A. The correlation between follicular measurements, oocyte morphology and fertilization rates in an in vitro fertilization program. Fertil Steril 1995; 64: 787-90.
18. Arnot A, Vanderckhove P, DeBono M, Rutherford A. Follicular volume and number during in vitro fertilization: association with oocyte developmental capacity and pregnancy rate. Hum Reprod 1995; 10: 256-61.
19. Miller K, Goldberg J, Falcone T. Follicle size and implantation of embryos from in vitro fertilization. Obstet Gynecol 1996; 88: 583-6.
20. Ectors F, Vanderzwalmen P, Van Hoeck J et al. Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod 1997; 12: 2002-5.
21. Bergh C, Broden H, Lundin K, Hamberger L. Comparison of fertilization, cleavage and pregnancy rates of oocytes from large and small follicles. Hum Reprod 1998; 13: 1912-5.
22. Salha O, Nugent D, Dada T et al. The relationship between follicular fluid aspirate volume and oocyte maturity in in-vitro fertilization cycles. Hum Reprod 1998; 13: 1901-6.
23. Triwitayakorn A, Suwajanakorn S, Pruksananonda K et al. Correlation between human follicular diameter and oocyte outcome in an ICSI program. J Assist Reprod Genet 2003; 20: 143-7.
24. Gerris J. Reducing the number of embryos to transfer after IVF/ICSI In Van Blerkom J, Gregory L, eds. Essential IVF: Basic Research and Clinical Applications. Boston: Kluwer Academic Publishers, 2004: 505-75.
25. Benagiano G, Gianaroli L. The new Italian IVF legislation. Reprod Biomed Online 2004: 9: 117-25.
26. Papanikolaou E, Camus M, Kolibiankakis E et al. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med 2006; 354: 1139-46.
27. Borini A. Predictive factors for embryo implantation potential. Reprod Biomed Online 2005; 10: 653-68.
28. Manna C, Nardo N. Italian law on assisted conception: clinical and research implications. Reprod Biomed Online 2005;11:532-4.
29. Strohmer H, Herczeg C, Plockinger B et al. Prognostic appraisal of success and failure of in vitro fertilization program by transvaginal Doppler ultrasound at the time of ovulation induction. Ultrasound Obstet Gynecol 1991; 1: 272-4.
30. Steer C, Campbell T, Tan S et al. The use of color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992; 57: 372-6.
31. Oyesanya O, Parsons J, Collins W et al. Prediction of oocyte recovery rate by transvaginal ultrasonography and color Doppler imaging before human chorionic gonadotropin administration in in vitro fertilization cycles. Fertil Steril 1996; 65: 806-9.
32. Nargund G, Doyle P, Bourne T et al. Association between ultrasound indices of follicular blood flow, oocyte recovery, and preimplantation embryo quality. Hum Reprod 1996; 11: 109-12.
33. Nargund G, Doyle P, Bourne T et al. Ultrasound derived indices of follicular blood flow before HCG administration and the prediction of oocyte recovery and preimplantation embryo quality. Hum Reprod 1996; 11: 2515-7.
34. Chui D, Jurovic D, Bourne T et al. Follicular vascularity - the predictive value of transvaginal power Doppler ultrasonography in an in vitro fertilization programme. A preliminary study. Hum Reprod 1997; 12: 191-6.
35. Van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997; 12: 1947-55.
36. Bahl P, Pugh N, Chui D et al. The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles. Hum Reprod 1999; 14: 939-45.
37. Coulam C, Goodman C, Rinehart J. Color Doppler indices of follicular blood flow as predictors of pregnancy after in-vitro fertilization and embryo transfer. Hum Reprod 1999; 14: 1979-82.
38. Huey S, Abuhamad A, Barrosa G et al. Perifollicular blood flow Doppler but not follicular pO2, pCo2, or pH, predict oocyte developmental competence in in vitro fertilization. Fertil Steril 1999; 72: 707-12.
39. Borini A, Maccolini A, Tallarini A et al. Perifollicular vascularity and its relationship with oocyte maturity and IVF outcome. Ann NY Acad Sci 2001; 943: 64-7.
40. Gregory L. Perifollicular vascularity: a marker of follicular heterogeneity and oocyte competence and a predictor of implantation in assisted conception cycles. In Van Blerkom J, Gregory L, eds. Essential IVF: Basic Research and Clinical Applications. Boston: Kluwer Academic Publishers, 2004: 59-80.
41. Van Blerkom J. Follicular influences on oocyte and embryo competence In DeJonge C, Barratt C, Eds. Assisted Reproductive Technology, Cambridge: Cambridge University Press, 2002: 81-105.
42. Bahl P, Pugh N, Gregory L et al. Perifollicular vascularity as a potential variable affecting outcome in stimulated intrauterine insemination treatment cycles: a study using transvaginal power Doppler. Hum Reprod 2001: 16; 1682-9.
43. Shrestha S, Costello M, Sjoblom P et al. Power Doppler ultrasound assessment of follicular vascularity in the early follicular phase and its relationship with outcome in in vitro fertilization. J Assist Reprod Genet 2006; 23: 161-9.
44. Palomba S, Russo T, Falbo A et al. Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study. Hum Reprod 2006; 21: 1055-61.
45. Merce L, Bau S, Barco M et al. Assessment of the ovarian volume, number and volume of follicles and ovarian vascularity by threedimensional ultrasonography and power Doppler angiography on the HCG day to predict the outcome in IVF/ICSI cycles. Hum Reprod 2006; 21: 1218-26.
46. Kim K, Oh D, Jeong J et al. Follicular blood flow is a better predictor of the outcome of in vitro fertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations. Fertil Steril 2004; 82: 586-92.
47. Pan H-A, Wu H-H, Cheng Y-C et al. Quantification of ovarian stromal Doppler signals in poor responders undergoing in vitro fertilization with three-dimensional power Doppler ultrasonography. Am J Obstet Gynecol 2004; 190: 338-44.
48. Bergqvist A, Bergqvist D, Ferno M. Estrogen and progesterone receptors in vessel walls: biochemical and immunochemical assays. Acta Obstet Gynecol Scand 1993; 72: 10-6.
49. Gislard V, Miller V, Van Houte P. Effects of 17ß-oestradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1998; 244: 19-22.
50. Kan A, Ng EH, Yeung WS, Ho PC. Perifollicular vascularity in poor ovarian responders during IVF. Hum Reprod 2006; 21: 1539-44.
51. Van Blerkom J. Epigenetic influences on oocyte developmental competence: Follicular oxygenation and perifollicular vascularity. J Assist Reprod Genet 1998; 15: 226-34.
52. Gaulden M. The enigma of Down syndrome and other trisomic conditions. Mutat Res 1992; 269: 68-88.
53. Battaglia D, Goodwin P, Klein N et al. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Mol Hum Reprod 1996; 11: 2217-22.
54. Clark A, Stokes Y, Lane M, Thompson J. Mathematical modelling of oxygen concentration in bovine and murine cumulus-oocyte complexes. Reproduction 2006; 131: 999-1006.
55. Dickey R, Matulich E. Ultrasound imaging at the beginning of the second millennium. In DeJonge C, Barratt C, eds. Assisted Reproductive Technology, Cambridge: Cambridge University Press, 2002: 282-301.
56. Antczak M. The synthetic and secretory behaviors (nonsteroidal) of ovarian follicular granulosa cells: parallels to cells of the endothelial cell lineage. In Van Blerkom J, Gregory L, Eds. Essential IVF: Basic Research and Clinical Applications. Boston: Kluwer Academic Publishers, 2004: 1-41.
57. Michael A. Do biochemical predictors of outcome exist? In Van Blerkom J, Gregory L, Eds. Essential IVF: Basic Research and Clinical Applications. Boston: Kluwer Academic Publishers, 2004: 81-110.
58. Malamitsi-Puchner A. Novel follicular fluid factors influencing oocyte developmental potential in IVF: a review. Reprod Biomed Online 2006; 12: 500-6.
59. Otani N, Minami S, Yamoto M et al. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. J Clin Endocrinol Metabol 1999; 84: 3845-51.
60. Yan Z, Neulen J, Raczek S et al. Vascular endothelial growth factor (VEGF)/vascularity permeability factor (VPF) production by luteinized human granulosa cells in vitro; a paracrine signal in corpus luteum formation. Gynecol Endocrinol 1993; 12: 145-53.
61. Antczak M, Van Blerkom J, Clark A. A novel mechanism of vascular endothelial growth factor, leptin and transforming growth factor beta2 sequestration in a subpopulation of human ovarian follicle cells. Hum Reprod 1997; 12: 2226-34.
62. Cioffi J, Van Blerkom J, Antczak M et al. The expression of leptin and its receptors in pre-ovulatory human follicles. Mol Hum Reprod 1997: 3: 467-72.
63. Bouloumie A, Drexler H, Lafontan M, Busse R. Leptin, the product of the ob gene, promotes angiogenesis. Circ Res 1998; 83: 1059-66.
64. Kamut B, Brown L, Mannseau E et al. Expression of vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 1995; 146: 157-65.
65. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5.
66. 2 homeostasis by hypoxiainducible factor 1. Ann Rev Cell Dev Biol 1999; 15: 551-78.
67. Bruick RK. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev 2003; 17: 2614-23.
68. Bell E, Brooke M, Emerling B, Navdeep S. Mitochondrial regulation of oxygen sensing. Mitochondrion 2005; 5: 322-32.
69. Bunn H, Poynton R. Oxygen sensing and molecular adaptations to hypoxia. Physiol Rev 1996; 76: 839-85.
70. Antczak M. Possible ramifications of the identification of ovarian follicular granulosa cells as specialized endothelial-like cells: a speculative treatise. Reprod Biomed Online 2001; 2: 188-97.
71. Artini P, Monti M, Fasciani A et al. Vascular endothelial cell growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome. Eur J Obset Gynecol Reprod Biol. 2002; 101: 169-74.
72. Friedman C, Seifer D, Kennard E et al. Elevated levels of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy
73. Tetsuka M, Haines L, Milne M et al. Regulation of 11ß-hydroxy-steroid dehydrogenase type 1 gene expression by LH and inter-leukin-1ß in cultured rat granulosa cells. J Endocrinol 1999; 163: 417-23.
74. Keay S, Harlow C, Wood P et al. Higher cortisol : cortisone ratios in the preovulatory follicle of unstimulated IVF cycles indicate oocytes with increased pregnancy potential. Hum Reprod 2002; 17: 2003-8.
75. Michael A, Gregory L, Thaventhiran L et al. Follicular variation in ovarian 11ß-hydroxysteroid dehydrogenase (11ßHSD) activities: evidence for the paracrine inhibition of 11ßHSD in human granulosa-lutein cells. J Endocrinol 1996;148: 419-25.
76. Durlinger A, Gruijeters M, Kramer P et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002; 143: 1976-84.
77. van Rooij I, Broekmans F, te Velde E et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002; 17: 3065-71.
78. Hazout A, Bouchard P, Seifer D et al. Serum antimullerian hor-mone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004; 82: 1323-9.
79. Seifer D, MacLaughlin D, Christian B et al. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77: 468-71.
80. Hirobe S, He W, Gustafson M, MacLaughlin D, Donahoe P. Mullerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection. Biol Reprod 1994; 50: 1238-43.
81. Fallat M, Siow Y, Marra M et al. Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril 1997; 67: 962-5.
82. Franchin R, Mendez Lozano D, Louafi N et al. Dynamics of serum anti-mullerian hormones levels during the luteal phase of controlled ovarian hyperstimulation. Hum Reprod 2005; 20: 747-51.
83. Silberstein T, MacLaughlin D, Shai I et al, Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predicts both ovarian reserve and embryo morphology. Hum Reprod 2006: 21: 159-63.
84. Eldar-Geva T, Ben-Chetrit A, Spitz I et al. Dynamic assays of inhibin B, anti-mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005; 20: 3178-83.
85. Groome N, Illingworth P, O'Brien M et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996; 814: 1401-5.
86. Fowler P, Fahy U, Culler M et al. Gonadotrophin surge-attenuating factor bioactivity is present in follicular fluid from naturally cycling women. Hum Reprod 1995; 10: 68-74.
87. Enskog A, Nilsoon L, Brannstrom M. Peripheral blood concentrations of inhibin B are elevated during gonadotrophin stimulation in patients who later develop ovarian OHSS and inhibin A concentrations are elevated after OHSS onset. Hum Reprod 2000; 15: 532-8.
88. Lau C, Ledger W, Groome NP et al. Dimeric inhibins and activin A in human follicular fluid and oocyte-cumulus culture media. Hum Reprod 1999; 14: 2525-30.
89. Chang C, Wang T, Horng S et al. The concentration of inhibin B in follicular fluid: relation to oocyte maturation and embryo development. Hum Reprod 2002; 17: 1724-8.
90. Urbancsek J, Hauzman E, Klinga K et al. Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproductive treatment outcome. Fertil Steril 2005; 83: 341-8.
91. Mendoza C, Ruiz-Requena E, Ortega E et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod 2002; 17: 1017-22.
92. Coulam C, Bustillo M, Schulman J. Empty follicle syndrome. Fertil Steril 1986; 46: 1153-5.
93. Ndukew G, Thornton S, Fishel S et al. Curing empty follicle syndrome. Hum Reprod 1997; 12: 21-3.
94. Tsuiki A, Rose B, Hung T. Steroid profiles of follicular fluids from a patient with empty follicle syndrome. Fertil Steril 1988; 49: 104-7.
95. Bustillo M. Unsuccessful oocyte retrieval: technical artifact or genuine 'empty follicle syndrome'. Reprod Biomed Online 2004; 8: 59-67.
96. Zreik TG, Garcia-Velasco J, Vergara T et al. Empty follicle syndrome: evidence for recurrence. Hum Reprod 2000; 15: 999-1002.
97. Hassan H, Saleh H, Khalil O et al. Double oocyte aspiration may be a solution for empty follicle syndrome. Case reports. Fertil Steril 1998; 69: 138-9.
98. Awoniyi A, Govindbhai J, Zierke S et al. Continuing the debate on empty follicle syndrome: can it be associated with normal bioavailability of ß-human chorionic gonadotropin on the day of oocyte recovery? Hum Reprod 1998: 13: 1281-4.
99. Yen S, Jaffe R, Barbieri R. Reproductive Endocrinology, 4th edn. WB Saunders, 1999, Philadelphia.
100. Faddy M, Gosden R. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 1996; 11: 1484-6.
101. Scheffer G, Broekmans F, Dorland M et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999; 72: 845-51.
102. Dunson D, Colombo B, Baird D. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 2002; 17: 1399-403.
103. Piette C, de Mouzon J, Bachelot A et al. In-vitro fertilization: influence of women's age on pregnancy rates. Hum Reprod 1990; 5: 56-9.
104. Faddy M, Gosden R, Gougeon A et al. Accelerated disappearance of ovarian follicles in mid-life-implications for forecasting menopause. Hum Reprod 1992; 7: 1342-6.
105. Henderson D, Edwards R. Chiasma frequency and maternal age in mammals. Nature 1968; 218: 22-8.
106. Volarcik K, Sheean L, Goldfarb J et al. The meiotic competence ofin vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary. Hum Reprod 1998; 13: 154-60.
107. Tarin J. Aetiology of age-associated aneuploidy: a mechanism based of the 'free radical theory of aging'. Mol Hum Reprod 1995; 1: 1563-5.
108. Crowley P, Gulah D, Hayden T et al. A chiasma-hormonal hypothesis relating Down's syndrome and maternal age. Nature 1979; 280: 417-8.
109. Santoro N, Isaac B, Neal-Perry G et al. Impaired folliculogenesis and ovulation in older reproductive age women. J Clin Endocrinol Metab 2003: 88: 5502-9.
110. Hansen K, Thyer A, Sluss P et al. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women? Hum Reprod 2005; 20: 89-95.
111. Ng E, Chan C, Yeung W et al. Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility. Hum Reprod 2004; 19: 2123-37.
112. Zenzes M, Wang P, Casper R. Cigarette smoking may affect meiotic maturation of human oocytes. Hum Reprod 1995; 10: 3213-7.
113. Zenzes M, Krishnan S, Krishnan B et al. Cadmium accumulation in follicular fluid of women in in vitro fertilization-embryo transfers is higher in smokers. Fertil Steril 1995; 64: 599-603.
114. Zenzes M, Reed T, Wang P et al. Cotinine, a major metabolite of nicotine, is detectable in follicular fluids of passive smokers in in vitro fertilization therapy. Fertil Steril 1996; 66: 614-19.
115. Zenzes M, Puy L, Bielecki R. Immunodetection of benzo[a]pyrene adducts in ovarian cells of women exposed to cigarette smoke. Mol Hum Reprod 1998; 4: 159-65.
116. Finkel T, Holbrook N. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408: 239-47.
117. Paszkowski T, Clarke RN, Hornstein MD. Smoking induces oxidative stress inside the Graafian follicle. Hum Reprod 2002; 17: 921-5.
118. Rosevear S, Holt D, Lee T et al. Smoking and decreased fertilisation rates in vitro. Lancet 1992; 340: 1195-6.
119. Westhoff C, Murphy P, Heller D. Predictors of ovarian follicle number. Fertil Steril 2000; 74: 624-8.
120. Midgette A, Baron J. Cigarette smoking and the risk of natural menopause. Epidemiology 1990; 6: 474-80.
121. Hassan M, Killick S. Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril 2004; 81: 384-92.
122. Carrell D. Body mass index is inversely related to intra-follicular HCG concentrations, embryo quality and IVF outcome. Reprod BioMed Online 2001; 3: 109-11.
123. Peters H. Intrauterine gonadal development. Fertil Steril 1976; 27: 493-500.
124. Van Blerkom J, Davis P. Differential effects of repeated ovarian stimulation on cytoplasmic and spindle organization in metaphase II mouse oocytes matured in vivo and in vitro. Hum Reprod 2001; 16: 757-64.
125. Doldi N, Persico P, De Santis L et al. Consecutive cycles in in vitro fertilization-embryo transfer. Gynecol Endocrinol 2005; 20: 132-6.
126. Hoveyda F, Engmann L, Steele J et al. Ovarian response in three consecutive in vitro fertilization cycles. Fertil Steril 2002; 77: 706-10.